PAR 0.00% 19.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-625

  1. 1,458 Posts.
    lightbulb Created with Sketch. 281
    “It should be short positions against volume - that's where the price damage is done”

    good point. I never thought of it from that angle.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.